Minnesota FOIA #N010533402

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)...

On August 29, 2023, the University of Colorado received a purchase order from TWIN_CITIES for a project titled 'Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)'. The contract involves a total obligated amount of $80,041, split into two line items: $63,541.33 for the therapy study and $16,500 for a fixed payment component. The vendor, University of Colorado, is located in Aurora, Colorado, USA, with NAICS code 621399 (Offices of All Other Miscellaneous Health Practitioners). The procurement likely involved health or medical research services. The primary recipient is the University of Colorado, and the buyer is TWIN_CITIES. Contact details for procurement officials are not provided. Likely competitors for similar awards include companies specializing in medical research and therapy development such as Medtronic, Abbott, and Boston Scientific.

Description

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX); Fixed Payment Component